November 30, 2005 03:29 ET

Proposed appointment of new member of Managing Board of Directors at DSM

HEERLEN, NETHERLANDS -- (MARKET WIRE) -- November 30, 2005 --

The Supervisory Board of DSM will propose to the Annual General Meeting on 29 March 2006 to appoint to the Managing Board with effect from the same date

Mr N. (Nico) Gerardu

Nico Gerardu is currently director of the DSM Anti-Infectives business group.

He is to succeed

Mr C.G. (Chris) Goppelsroeder

who, after careful consideration, has decided to relinquish his position for personal reasons per 29 March 2006.

It is with much regret that DSM has to announce that Mr Goppelsroeder is leaving DSM. As a Managing Board member he has been responsible for a number of businesses in several of DSM's clusters. Chris Goppelsroeder has been instrumental in the establishment of DSM's new strategic direction as outlined in the Vision 2010 - Building on Strengths program. Prior to his appointment to the DSM Managing Board of Directors, he was vital to the integration and transformation of DSM Nutritional Products.

Nico Gerardu (54) has worked with DSM since 1975. He joined DSM at the company's Engineering department and has worked in different management positions in several business groups: Industrial Chemicals, Plastics, Plastic Products, Fine Chemicals and lastly DSM Anti-Infectives, where he has been business group director since 2000. Mr Gerardu studied Physical Technology at the Eindhoven (Netherlands) University of Technology and has an MBA from Diepenbeek (Belgium).

Nico Gerardu will prepare for his new position as from 1 January 2006.


DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company creates innovative products and services that help improve the quality of life. DSM's products are used in a wide range of end markets and applications such as human and animal nutrition and health, cosmetics, pharmaceuticals, automotive and transport, coatings, housing and electrics & electronics (E&E). DSM's strategy, named Vision 2010 - Building on Strengths, focuses on accelerating profitable and innovative growth of the company's specialties portfolio. Market-driven growth, innovation and increased presence in emerging economies are key drivers of this strategy. The group has annual sales of approximately EUR 8 billion and employs around 23,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia and the Americas. More information about DSM can be found at

For more information:

DSM Corporate Communications
Médard Schoenmaeckers
tel. +31 (0) 45 5782035
fax +31 (0) 45 5740680

DSM Investor Relations
Dries Ausems
tel. +31 (0) 45 5782864
fax +31 (0) 45 5782595

Copyright © Hugin ASA 2005. All rights reserved.

Contact Information